These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 8128782
1. [Plasminogen activator-inhibitor 1: biochemical, structural and functional studies]. Declerck P. Verh K Acad Geneeskd Belg; 1993; 55(5):457-73. PubMed ID: 8128782 [Abstract] [Full Text] [Related]
2. Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation. Kjøller L, Kanse SM, Kirkegaard T, Rodenburg KW, Rønne E, Goodman SL, Preissner KT, Ossowski L, Andreasen PA. Exp Cell Res; 1997 May 01; 232(2):420-9. PubMed ID: 9168821 [Abstract] [Full Text] [Related]
3. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries. Stoop AA, Eldering E, Dafforn TR, Read RJ, Pannekoek H. J Mol Biol; 2001 Jan 26; 305(4):773-83. PubMed ID: 11162091 [Abstract] [Full Text] [Related]
4. Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop. Debrock S, Declerck PJ. Thromb Haemost; 1998 Mar 26; 79(3):597-601. PubMed ID: 9531048 [Abstract] [Full Text] [Related]
5. Substrate behavior of plasminogen activator inhibitor-1 is not associated with a lack of insertion of the reactive site loop. Gils A, Knockaert I, Declerck PJ. Biochemistry; 1996 Jun 11; 35(23):7474-81. PubMed ID: 8652525 [Abstract] [Full Text] [Related]
6. Modulation of plasminogen activator inhibitor 1 by Triton X-100--identification of two consecutive conformational transitions. Gils A, Declerck PJ. Thromb Haemost; 1998 Aug 11; 80(2):286-91. PubMed ID: 9716154 [Abstract] [Full Text] [Related]
7. Characterization of recombinant rat plasminogen activator inhibitor-1 and development of immunological tools for its quantitation. Ngo TH, Verheyen S, Knockaert I, Declerck PJ. J Pharm Belg; 1997 Aug 11; 52(4):165-6. PubMed ID: 9316343 [Abstract] [Full Text] [Related]
8. Vitronectin and substitution of a beta-strand 5A lysine residue potentiate activity-neutralization of PA inhibitor-1 by monoclonal antibodies against alpha-helix F. Schousboe SL, Egelund R, Kirkegaard T, Preissner KT, Rodenburg KW, Andreasen PA. Thromb Haemost; 2000 May 11; 83(5):742-51. PubMed ID: 10823273 [Abstract] [Full Text] [Related]
15. The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors. Gils A. Verh K Acad Geneeskd Belg; 2006 May 11; 68(3):179-98. PubMed ID: 16796017 [Abstract] [Full Text] [Related]
16. High-density mutagenesis by combined DNA shuffling and phage display to assign essential amino acid residues in protein-protein interactions: application to study structure-function of plasminogen activation inhibitor 1 (PAI-I). Stoop AA, Jespers L, Lasters I, Eldering E, Pannekoek H. J Mol Biol; 2000 Sep 01; 301(5):1135-47. PubMed ID: 10966811 [Abstract] [Full Text] [Related]
20. The molecular basis for anti-proteolytic and non-proteolytic functions of plasminogen activator inhibitor type-1: roles of the reactive centre loop, the shutter region, the flexible joint region and the small serpin fragment. Wind T, Hansen M, Jensen JK, Andreasen PA. Biol Chem; 2002 Jan 01; 383(1):21-36. PubMed ID: 11928815 [Abstract] [Full Text] [Related] Page: [Next] [New Search]